S1 Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO
NCT05037929COPDastegolimab
…sed, double-blind, placebo-controlled Phase IIb ALIENTO trial ( NCT05037929) evaluated efficacy and safety of astegolimab (anti-ST2) in COP…